Benchaoui HA et al., 1996: Goat and sheep study showing that piperonyl butoxide, a P450 inhibitor, more than triples fenbendazole bioavailability and restores efficacy against benzimidazole-resistant worms.
Pretreatment of goats with the inhibitor caused a greater than three-fold increase in the relative bioavailability of fenbendazole and fenbendazole sulphoxide.
Benchaoui HA et al., 1996: Goat and sheep study showing that piperonyl butoxide, a P450 inhibitor, more than triples fenbendazole bioavailability and restores efficacy against benzimidazole-resistant worms. Animal PK and efficacy study; sheep and goats; United Kingdom (University of Glasgow); fenbendazole 5 mg/kg with piperonyl butoxide 0-250 mg/kg orally; efficacy tested against Ostertagia circumcincta and Haemonchus contortus. Funder: not stated. Declared conflicts: none recorded. Comparator: fenbendazole alone, and untreated/resistant-worm controls. The clearest demonstration in this record that a co-administered P450 inhibitor changes both exposure and effect. Study type: animal.
